Cite
MLA Citation
Amit Bahl et al.. “Final quality of life and safety data for patients with metastatic castration‐resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279).” BJU international, vol. 116, n.d., pp. 880–887. http://access.bl.uk/ark:/81055/vdc_100027710362.0x000014